{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:03:23Z","timestamp":1793646203334,"version":"4.5.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG057409"],"award-info":[{"award-number":["RF1 AG057409"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG056259"],"award-info":[{"award-number":["R01 AG056259"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA048882"],"award-info":[{"award-number":["R01 DA048882"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R35 AG071734"],"award-info":[{"award-number":["R35 AG071734"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DP1 DA041722"],"award-info":[{"award-number":["DP1 DA041722"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R61 NS122098"],"award-info":[{"award-number":["R61 NS122098"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 NS123298"],"award-info":[{"award-number":["RF1 NS123298"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG061845"],"award-info":[{"award-number":["R01 AG061845"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007384"],"award-info":[{"award-number":["T32AI007384"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["T32 EB009380"],"award-info":[{"award-number":["T32 EB009380"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM132826"],"award-info":[{"award-number":["R01 GM132826"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI144462"],"award-info":[{"award-number":["UM1 AI144462"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P41 GM103533"],"award-info":[{"award-number":["P41 GM103533"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2 COVID19-11811"],"award-info":[{"award-number":["DISC2 COVID19-11811"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COVID-19 awards from Fast Grants"},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-004923"],"award-info":[{"award-number":["INV-004923"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MCB-2032054"],"award-info":[{"award-number":["MCB-2032054"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the RCSA Research Corp. and a UC San Diego Moore\u2019s Cancer Center 2020 SARS-CoV-2 seed grant"},{"DOI":"10.13039\/100009053","name":"Bill and Melinda Gates Institute for Population and Reproductive Health","doi-asserted-by":"publisher","award":["OPP1107194"],"award-info":[{"award-number":["OPP1107194"]}],"id":[{"id":"10.13039\/100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41589-022-01149-6","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T12:08:39Z","timestamp":1664453319000},"page":"275-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2489-4072","authenticated-orcid":false,"given":"Chang-ki","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Beutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pi\u00f1a-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Talantova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swagata","family":"Ghatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Trudler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-0481","authenticated-orcid":false,"given":"Lauren N.","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"McKercher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malina A.","family":"Bakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene K.","family":"Diedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley K.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-8231","authenticated-orcid":false,"given":"Mia A.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona L.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3581-1148","authenticated-orcid":false,"given":"Lorenzo","family":"Casalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namir","family":"Shaabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-7853","authenticated-orcid":false,"given":"Hejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-2419","authenticated-orcid":false,"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-9553","authenticated-orcid":false,"given":"Rommie E.","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6711-9864","authenticated-orcid":false,"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-1672","authenticated-orcid":false,"suffix":"III","given":"John R.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-464X","authenticated-orcid":false,"given":"Cyrus","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5171-7982","authenticated-orcid":false,"given":"Arnab K.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3490-1259","authenticated-orcid":false,"given":"Stuart A.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"1149_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"1149_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.tibs.2010.03.006","volume":"35","author":"D Kozakov","year":"2010","unstructured":"Kozakov, D., Chuang, G. Y., Beglov, D. & Vajda, S. Where does amantadine bind to the influenza virus M2 proton channel? Trends Biochem. Sci. 35, 471\u2013475 (2010).","journal-title":"Trends Biochem. Sci."},{"key":"1149_CR3","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1110\/ps.062730007","volume":"16","author":"J Torres","year":"2007","unstructured":"Torres, J. et al. Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein. Protein Sci. 16, 2065\u20132071 (2007).","journal-title":"Protein Sci."},{"key":"1149_CR4","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1016\/j.cell.2021.04.033","volume":"184","author":"D Asarnow","year":"2021","unstructured":"Asarnow, D. et al. Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia. Cell 184, 3192\u20133204 (2021).","journal-title":"Cell"},{"key":"1149_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrd1958","volume":"5","author":"SA Lipton","year":"2006","unstructured":"Lipton, S. A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 5, 160\u2013170 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1149_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/156720506777632808","volume":"3","author":"Y Wang","year":"2006","unstructured":"Wang, Y. et al. The pharmacology of aminoadamantane nitrates. Curr. Alzheimer Res. 3, 201\u2013204 (2006).","journal-title":"Curr. Alzheimer Res."},{"key":"1149_CR7","doi-asserted-by":"publisher","first-page":"E2518","DOI":"10.1073\/pnas.1306832110","volume":"110","author":"M Talantova","year":"2013","unstructured":"Talantova, M. et al. A\u03b2 induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Proc. Natl Acad. Sci. USA 110, E2518\u2013E2527 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1149_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01563-8","volume":"8","author":"S Tu","year":"2017","unstructured":"Tu, S. et al. NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nat. Commun. 8, 1488 (2017).","journal-title":"Nat. Commun."},{"key":"1149_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep14781","volume":"5","author":"H Takahashi","year":"2015","unstructured":"Takahashi, H. et al. Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease. Sci. Rep. 5, 14781 (2015).","journal-title":"Sci. Rep."},{"key":"1149_CR10","doi-asserted-by":"publisher","first-page":"e1000511","DOI":"10.1371\/journal.ppat.1000511","volume":"5","author":"K Pervushin","year":"2009","unstructured":"Pervushin, K. et al. Structure and inhibition of the SARS coronavirus envelope protein ion channel. PLoS Pathog. 5, e1000511 (2009).","journal-title":"PLoS Pathog."},{"key":"1149_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","volume":"16","author":"D Schoeman","year":"2019","unstructured":"Schoeman, D. & Fielding, B. C. Coronavirus envelope protein: current knowledge. Virol. J. 16, 69 (2019).","journal-title":"Virol. J."},{"key":"1149_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrmicro2820","volume":"10","author":"JL Nieva","year":"2012","unstructured":"Nieva, J. L., Madan, V. & Carrasco, L. Viroporins: structure and biological functions. Nat. Rev. Microbiol. 10, 563\u2013574 (2012).","journal-title":"Nat. Rev. Microbiol."},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41594-020-00536-8","volume":"27","author":"VS Mandala","year":"2020","unstructured":"Mandala, V. S. et al. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat. Struct. Mol. Biol. 27, 1202\u20131208 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1149_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40268-021-00351-6","volume":"21","author":"RF Butterworth","year":"2021","unstructured":"Butterworth, R. F. Potential for the repurposing of adamantane antivirals for COVID-19. Drugs R D 21, 267\u2013272 (2021).","journal-title":"Drugs R D"},{"key":"1149_CR15","doi-asserted-by":"crossref","unstructured":"Akaberi, D. et al. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol. 101734 (2020).","DOI":"10.1016\/j.redox.2020.101734"},{"key":"1149_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.niox.2020.07.003","volume":"103","author":"NC Adusumilli","year":"2020","unstructured":"Adusumilli, N. C., Zhang, D., Friedman, J. M. & Friedman, A. J. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide 103, 4\u20138 (2020).","journal-title":"Nitric Oxide"},{"key":"1149_CR17","doi-asserted-by":"publisher","first-page":"e01283","DOI":"10.1128\/JVI.01283-20","volume":"94","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. SARS-CoV-2 and three related coronaviruses utilize multiple ACE2 orthologs and are potently blocked by an improved ACE2-Ig. J. Virol. 94, e01283\u201320 (2020).","journal-title":"J. Virol."},{"key":"1149_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/jclinpath-2020-206987","volume":"73","author":"M Thunders","year":"2020","unstructured":"Thunders, M. & Delahunt, B. Gene of the month: TMPRSS2 (transmembrane serine protease 2). J. Clin. Pathol. 73, 773\u2013776 (2020).","journal-title":"J. Clin. Pathol."},{"key":"1149_CR19","doi-asserted-by":"crossref","unstructured":"Cai, Y. et al. Distinct conformational states of SARS-CoV-2 spike protein. Science 369, 1586\u20131592 (2020).","DOI":"10.1126\/science.abd4251"},{"key":"1149_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. F., Xu, W. & Liu, S. W. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 41, 1141\u20131149 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"1149_CR21","doi-asserted-by":"publisher","first-page":"eaaw0843","DOI":"10.1126\/science.aaw0843","volume":"371","author":"T Nakamura","year":"2021","unstructured":"Nakamura, T. et al. Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer\u2019s disease. Science 371, eaaw0843 (2021).","journal-title":"Science"},{"key":"1149_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.bpj.2020.10.036","volume":"120","author":"EP Barros","year":"2020","unstructured":"Barros, E. P. et al. The flexibility of ACE2 in the context of SARS-CoV-2 infection. Biophys. J. 120, 1072\u20131084 (2020).","journal-title":"Biophys. J."},{"key":"1149_CR23","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"1149_CR24","doi-asserted-by":"crossref","unstructured":"Casalino, L. et al. AI-driven multiscale simulations illuminate mechanisms of SARS-CoV-2 spike dynamics. Int. J. High Perform. Comput. Appl. https:\/\/journals.sagepub.com\/doi\/10.1177\/10943420211006452 (2021).","DOI":"10.1101\/2020.11.19.390187"},{"key":"1149_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbrc.2020.05.206","volume":"530","author":"PP Singh Tomar","year":"2020","unstructured":"Singh Tomar, P. P. & Arkin, I. T. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by gliclazide and memantine. Biochem. Biophys. Res. Commun. 530, 10\u201314 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1149_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.virol.2006.05.028","volume":"353","author":"L Wilson","year":"2006","unstructured":"Wilson, L., Gage, P. & Ewart, G. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication. Virology 353, 294\u2013306 (2006).","journal-title":"Virology"},{"key":"1149_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269\u2013271 (2020).","journal-title":"Cell Res."},{"key":"1149_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou, X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 11, 1620 (2020).","journal-title":"Nat. Commun."},{"key":"1149_CR29","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto, S. et al. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med. 15, 1407\u20131413 (2009).","journal-title":"Nat. Med."},{"key":"1149_CR30","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1089\/ars.2017.7403","volume":"30","author":"CT Stomberski","year":"2019","unstructured":"Stomberski, C. T., Hess, D. T. & Stamler, J. S. Protein S-nitrosylation: determinants of specificity and enzymatic regulation of S-nitrosothiol-based signaling. Antioxid. Redox Signal. 30, 1331\u20131351 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"1149_CR31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers, T. F. et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science 369, 956\u2013963 (2020).","journal-title":"Science"},{"key":"1149_CR32","doi-asserted-by":"publisher","first-page":"2100348","DOI":"10.2807\/1560-7917.ES.2021.26.16.2100348","volume":"26","author":"T Funk","year":"2021","unstructured":"Funk, T. et al. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU\/EEA countries, weeks 38\/2020 to 10\/2021. Eur. Surveill. 26, 2100348 (2021).","journal-title":"Eur. Surveill."},{"key":"1149_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"1149_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0896-6273(00)80310-4","volume":"18","author":"JS Stamler","year":"1997","unstructured":"Stamler, J. S., Toone, E. J., Lipton, S. A. & Sucher, N. J. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18, 691\u2013696 (1997).","journal-title":"Neuron"},{"key":"1149_CR35","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1073\/pnas.0600729103","volume":"103","author":"TM Greco","year":"2006","unstructured":"Greco, T. M. et al. Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc. Natl Acad. Sci. USA 103, 7420\u20137425 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1149_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cbpa.2012.10.016","volume":"16","author":"BC Smith","year":"2012","unstructured":"Smith, B. C. & Marletta, M. A. Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr. Opin. Chem. Biol. 16, 498\u2013506 (2012).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"1149_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.abb.2016.10.015","volume":"617","author":"JR Lancaster Jr.","year":"2017","unstructured":"Lancaster, J. R. Jr. How are nitrosothiols formed de novo in vivo? Arch. Biochem. Biophys. 617, 137\u2013144 (2017).","journal-title":"Arch. Biochem. Biophys."},{"key":"1149_CR38","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/cid\/ciaa644","volume":"71","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. 71, 2428\u20132446 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"1149_CR39","doi-asserted-by":"publisher","first-page":"eabj5413","DOI":"10.1126\/scitranslmed.abj5413","volume":"13","author":"H Cho","year":"2021","unstructured":"Cho, H. et al. Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern. Sci. Transl. Med. 13, eabj5413 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1149_CR40","doi-asserted-by":"publisher","first-page":"eabj7790","DOI":"10.1126\/scitranslmed.abj7790","volume":"13","author":"F D\u2019Agnillo","year":"2021","unstructured":"D\u2019Agnillo, F. et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci. Transl. Med. 13, eabj7790 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1149_CR41","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1002\/sim.7495","volume":"36","author":"M Doi","year":"2017","unstructured":"Doi, M., Takahashi, F. & Kawasaki, Y. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test. Stat. Med. 36, 4789\u20134803 (2017).","journal-title":"Stat. Med."},{"key":"1149_CR42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450\u2013454 (2003).","journal-title":"Nature"},{"key":"1149_CR43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature04782","volume":"441","author":"T Uehara","year":"2006","unstructured":"Uehara, T. et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441, 513\u2013517 (2006).","journal-title":"Nature"},{"key":"1149_CR44","doi-asserted-by":"publisher","first-page":"e50333","DOI":"10.7554\/eLife.50333","volume":"8","author":"S Ghatak","year":"2019","unstructured":"Ghatak, S. et al. Mechanisms of hyperexcitability in Alzheimer\u2019s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls. eLife 8, e50333 (2019).","journal-title":"eLife"},{"key":"1149_CR45","doi-asserted-by":"publisher","first-page":"11361","DOI":"10.1021\/acs.analchem.5b02721","volume":"87","author":"L He","year":"2015","unstructured":"He, L., Diedrich, J., Chu, Y. Y. & Yates, J. R. III Extracting accurate precursor information for tandem mass spectra by RawConverter. Anal. Chem. 87, 11361\u201311367 (2015).","journal-title":"Anal. Chem."},{"key":"1149_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jprot.2015.07.001","volume":"129","author":"T Xu","year":"2015","unstructured":"Xu, T. et al. ProLuCID: an improved SEQUEST-like algorithm with enhanced sensitivity and specificity. J. Proteom. 129, 16\u201324 (2015).","journal-title":"J. Proteom."},{"key":"1149_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1021\/pr015504q","volume":"1","author":"DL Tabb","year":"2002","unstructured":"Tabb, D. L., McDonald, W. H. & Yates, J. R. III DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1, 21\u201326 (2002).","journal-title":"J. Proteome Res."},{"key":"1149_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/pr025556v","volume":"2","author":"J Peng","year":"2003","unstructured":"Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L. J. & Gygi, S. P. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC\/LC\u2013MS\/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2, 43\u201350 (2003).","journal-title":"J. Proteome Res."},{"key":"1149_CR49","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/ci3003649","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K., Raman, E. P. & MacKerell, A. D. Jr. Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J. Chem. Inf. Model. 52, 3155\u20133168 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"1149_CR50","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. Jr. Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model. 52, 3144\u20133154 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"1149_CR51","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcc.23067","volume":"33","author":"W Yu","year":"2012","unstructured":"Yu, W., He, X., Vanommeslaeghe, K. & MacKerell, A. D. Jr. Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations. J. Comput. Chem. 33, 2451\u20132468 (2012).","journal-title":"J. Comput. Chem."},{"key":"1149_CR52","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/ijms20092167","volume":"20","author":"D Casares","year":"2019","unstructured":"Casares, D., Escriba, P. V. & Rossello, C. A. Membrane lipid composition: effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues. Int. J. Mol. Sci. 20, 2167 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1149_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer, G., Voelker, D. R. & Feigenson, G. W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112\u2013124 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1149_CR54","doi-asserted-by":"publisher","first-page":"044130","DOI":"10.1063\/5.0014475","volume":"153","author":"JC Phillips","year":"2020","unstructured":"Phillips, J. C. et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153, 044130 (2020).","journal-title":"J. Chem. Phys."},{"key":"1149_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"1149_CR56","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1021\/ct900242e","volume":"5","author":"O Guvench","year":"2009","unstructured":"Guvench, O., Hatcher, E. R., Venable, R. M., Pastor, R. W. & Mackerell, A. D. CHARMM additive all-atom force field for glycosidic linkages between hexopyranoses. J. Chem. Theory Comput. 5, 2353\u20132370 (2009).","journal-title":"J. Chem. Theory Comput."},{"key":"1149_CR57","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","volume":"109","author":"RT McGibbon","year":"2015","unstructured":"McGibbon, R. T. et al. MDTraj: a modern open library for the analysis of molecular dynamics trajectories. Biophys. J. 109, 1528\u20131532 (2015).","journal-title":"Biophys. J."},{"key":"1149_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 27\u201338 (1996). 33-38.","journal-title":"J. Mol. Graph."},{"key":"1149_CR59","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.18632\/oncotarget.27799","volume":"11","author":"L Zhou","year":"2020","unstructured":"Zhou, L. et al. MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection. Oncotarget 11, 4201\u20134223 (2020).","journal-title":"Oncotarget"},{"key":"1149_CR60","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-022-04661-w","volume":"605","author":"T Shapira","year":"2022","unstructured":"Shapira, T. et al. A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature 605, 340\u2013348 (2022).","journal-title":"Nature"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01149-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T09:10:11Z","timestamp":1700471411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-022-01149-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1038\/s41589-022-01149-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.05.487060","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that S.A.L. is an inventor on patents for the use of memantine and various aminoadamantane nitrate compounds for neurodegenerative and neurodevelopmental disorders. He is also an inventor on composition of matter patents and use patents for aminoadamantane nitrate compounds in treating COVID-19 and other viral diseases. Per Harvard University guidelines, S.A.L. participates in a royalty-sharing agreement with his former institution, Boston Children\u2019s Hospital\/Harvard Medical School, which licensed the drug memantine (Namenda) to Forest Laboratories\/Actavis\/Allergan\/AbbVie for use in dementia. The aminoadamantane nitrate compounds have been licensed to EuMentis Therapeutics. C.B. is a chemist employed at EuMentis Therapeutics. The other authors declare no financial conflicts of interest relevant to this publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}